Bayer was abruptly evicted from the agro Shangri La and the pharma business was a mixed and more costly bag. This led to some differences with the consensus (sales: -1.4%; adjusted EBITDA: -3.5%). These things happen, but they never help change muted sentiment into a positive. Managing expectations might have been a good idea.
